CN110179799A - The application of tetrandrine and the extracting method of tetrandrine - Google Patents

The application of tetrandrine and the extracting method of tetrandrine Download PDF

Info

Publication number
CN110179799A
CN110179799A CN201910536829.6A CN201910536829A CN110179799A CN 110179799 A CN110179799 A CN 110179799A CN 201910536829 A CN201910536829 A CN 201910536829A CN 110179799 A CN110179799 A CN 110179799A
Authority
CN
China
Prior art keywords
tetrandrine
rat
weight
parts
solids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910536829.6A
Other languages
Chinese (zh)
Other versions
CN110179799B (en
Inventor
左红艳
杜丽娜
金义光
李杨
张丽花
朱思庆
庞璐璐
马金秋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Pharmacology and Toxicology of AMMS
Academy of Military Medical Sciences AMMS of PLA
Original Assignee
Institute of Pharmacology and Toxicology of AMMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Pharmacology and Toxicology of AMMS filed Critical Institute of Pharmacology and Toxicology of AMMS
Priority to CN201910536829.6A priority Critical patent/CN110179799B/en
Publication of CN110179799A publication Critical patent/CN110179799A/en
Application granted granted Critical
Publication of CN110179799B publication Critical patent/CN110179799B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4748Quinolines; Isoquinolines forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of applications of tetrandrine, and the extracting method of tetrandrine, specifically application and its extracting method of the tetrandrine in treatment rat microwave radiation cerebral injury, rat escape latency can be significantly reduced in tetrandrine, rat Spatial memory ability is improved, rat spirit of exploration and autonomic activities behavior are enhanced.

Description

The application of tetrandrine and the extracting method of tetrandrine
Technical field
The present invention relates to chemical fields.It is more particularly related to a kind of application of tetrandrine and tetrandrine Extracting method.
Background technique
Tetrandrine, also known as tetrandrine are also known as tetrandrine, and tetrandrine A prime is colorless needle crystals, main to use In analgesia, flesh pine, antiallergy, anti-arrhythmia, the antitumor decompression anticoagulant of antibacterial.Tetrandrine is mainly mentioned from Fourstamen Stephania Root It takes.Fourstamen Stephania Root is the dry root of Menispermaceae plant powder Radix Stephaniae Tetrandrae, has effects that inducing diuresis for removing edema, wind-expelling pain-stopping, modern pharmacology experiment Show that Fourstamen Stephania Root total alkaloid has analgesia, decompression, myorelaxant effects.Alkaloid is higher in Fourstamen Stephania Root, general reachable 1.5~2.0%, wherein mainly tetrandrine, followed by fangchinoline.
It is more about the patent and document of the extraction of tetrandrine at present, mainly use alcohol extraction and acid precipitation method, supercritical fluid There are many deficiencies in extraction or sour water percolation etc..And tetrandrine is methoxyl group, fangchinoline is phenolic hydroxyl group, powder The polarity of menispermine is smaller, can be dissolved in cold benzene, and fangchinoline polarity is larger, is insoluble in cold benzene, therefore generally using cold benzene point From tetrandrine and fangchinoline, but cold benzene is more toxic, and the influence of health and environment to operator is larger and mentions It takes that rate is low, waste liquid amount is big, pollutes environment.
Summary of the invention
It is an object of the invention to solve at least the above problems, and provide the advantages of at least will be described later.
It is an object of the present invention to provide a kind of applications of tetrandrine, and specifically tetrandrine is in treatment rat The extracting method of application and tetrandrine in microwave radiation cerebral injury, tetrandrine, which can be significantly reduced rat and escape, hides Phase improves rat Spatial memory ability, enhances rat spirit of exploration and autonomic activities behavior.
In order to realize purposes and other advantages according to the present invention, a kind of application of tetrandrine, tetrandrine are provided Application in treatment rat microwave radiation cerebral injury.
The present invention also provides a kind of for treating the extracting method of the tetrandrine of rat microwave radiation cerebral injury, comprising:
S1, it takes the Fourstamen Stephania Root of 100~120 parts by weight to clean, dry, crush, obtains Fourstamen Stephania Root powder, then to Fourstamen Stephania Root powder The water of 300~500 parts by weight and the solid sodium chloride of 30~50 parts by weight are added in end, then is placed in the ultrasonic wave of 30~50kHz 20~30min of middle processing, obtains the first mixed liquor, is then placed in the first mixed liquor in the electric field that electric current is 4~8mA, is passed through CO2 Gas, CO2The flow velocity that is passed through of gas is 20mL/min, and being passed through the time is 15~25min, obtains the second mixed liquor;
S2, the second mixed liquor is placed in a centrifuge, 20~30min, removal is centrifuged with the revolving speed of 5000~8000r/min Sediment takes supernatant, then supernatant is dissolved in the first diethyl ether solution of 30~50 parts by weight, obtains third mixed liquor, then Third mixed liquor is placed in 40~50min of water-bath heating and refluxing extraction at 70~80 DEG C, filters, obtains the first solids, wherein the The volume ratio of ether and water is 2:1 in one diethyl ether solution;
S3, the ether of 30~50 parts by weight and the water of 50~80 parts by weight are added into the first solids and is uniformly mixed, The quick lime of 20~30 parts by weight is added, is filtered after stirring 20~30min, obtains the second solids, then the second solids is molten In the second diethyl ether solution of 4 DEG C of 30~50 parts by weight, diethyl ether solution is then heated to by no ether with the speed of 5 DEG C/min Until smell escapes, filtering, drying obtain tetrandrine, wherein the volume ratio of ether and water is 1:3 in the second diethyl ether solution.
Preferably, the extracting method of the tetrandrine for treating rat microwave radiation cerebral injury, step S1 The partial size of middle Fourstamen Stephania Root powder is 80~100nm.
Preferably, the extracting method of the tetrandrine for treating rat microwave radiation cerebral injury, step S3 In when quick lime is added, N is passed through with the flow velocity of 10mL/min2Gas, N2The time that is passed through of gas is 25~35min.
Preferably, the extracting method of the tetrandrine for treating rat microwave radiation cerebral injury, step S3 In the first solids need to be purified before ether and water is added, purification process are as follows: the first solids is dissolved in 10~15 weights The ether of part is measured, then will be dissolved with the ether cation exchange resin exchange adsorption of the first solids, then use diethylether-ethanol Solution elutes the cation exchange resin column of adsorption saturation, flow velocity 5mL/min, until outflow eluent inanimate object alkali reaction is Only, the volume ratio of ether and ethyl alcohol is 1:2 in diethylether-ethanol solution.
Preferably, the extracting method of the tetrandrine for treating rat microwave radiation cerebral injury, step S3 Middle drying is cryogenic vacuum spray drying, and the vacuum degree of cryogenic vacuum spray drying is 6~8Pa, and temperature is 60 DEG C.
The present invention is include at least the following beneficial effects:
1, tetrandrine is applied to treatment rat microwave radiation cerebral injury by the present invention, and it is latent to significantly reduce rat average escape Fu Qi improves Spatial memory ability, enhances rat spirit of exploration and increases autonomic activities behavior.
2, the present invention uses and is passed through CO into the first mixed liquor2The method of gas, CO2Gas be dissolved in the first mixed liquor with Water reaction generates carbonic acid, and the first mixed liquor is made to have certain acidity, in order to extract the alkaloid in Fourstamen Stephania Root, and use to CO is passed through in first mixed liquor2Gas changes the method for the first pH of mixed degree, can reinforce first while experiment mixed The order of contact in liquid between each component is closed, there is certain mixing effect, and reduces fangchinoline and oxidation reaction generation occurs Other substances generate new impurity, to improve the extraction effect of tetrandrine.
3, the present invention purifies the second solids using diethyl ether solution to extract tetrandrine, and the second solids is first dissolved in second In ethereal solution, then Ether solution, during heating, ether is gradually reduced to no ether, Fourstamen Stephania Root in diethyl ether solution Alkali is gradually decreased in the solubility of diethyl ether solution, and tetrandrine crystallization is precipitated, and obtains the tetrandrine of high-purity.
Further advantage, target and feature of the invention will be partially reflected by the following instructions, and part will also be by this The research and practice of invention and be understood by the person skilled in the art.
Detailed description of the invention
Fig. 1 is the water maze laboratory rats'swimming trajectory diagram of the present invention in one embodiment;
Fig. 2 is the bar shaped that the tetrandrine of the present invention in another embodiment influences rat average escape latency Figure;
Fig. 3 is the bar chart that the tetrandrine of the present invention in another embodiment crosses over platform times influence to rat;
Fig. 4 is each group rat of the present invention in another embodiment typical path figure in spacious field experiment;
Fig. 5 is the bar chart of influence of the tetrandrine to rat total activity distance of the present invention in another embodiment;
Fig. 6 is the bar chart that the tetrandrine of the present invention in another embodiment influences rat average speed;
Fig. 7 is that the tetrandrine of the present invention in another embodiment accounts for total distance ratio to rat middle section activity distance The bar chart of the influence of example;
Fig. 8 is the influence that the tetrandrine of the present invention in another embodiment damages Rat hippocampus morphosis Electron microscope;
Fig. 9 is that the tetrandrine of the present invention in another embodiment is super to microwave radiation brain injury rat hippocampus neuron The electron microscope that micro-structure influences;
Figure 10 is the tetrandrine of the present invention in another embodiment to microwave radiation brain injury in rats neuronal synapse The electron microscope of ultrastructural influence;
Figure 11 is that the tetrandrine of the present invention in another embodiment is super to microwave radiation brain injury rat hippocampus blood vessel The electron microscope that micro-structure influences.
Specific embodiment
Below with reference to embodiment and attached drawing, the present invention is described in further detail, to enable those skilled in the art's reference Specification word can be implemented accordingly.
It should be noted that experimental method described in following embodiments is unless otherwise specified conventional method, it is described Reagent and material commercially obtain unless otherwise specified.
Embodiment 1:
The present invention provides a kind of for treating the extracting method of the tetrandrine of rat microwave radiation cerebral injury, comprising:
S1, it takes the Fourstamen Stephania Root of 100 parts by weight to clean, dry, crush, Fourstamen Stephania Root powder is obtained, then into Fourstamen Stephania Root powder The water of 300 parts by weight and the solid sodium chloride of 30 parts by weight is added, then is placed in the ultrasonic wave of 30kHz and handles 20min, obtains first Then first mixed liquor is placed in the electric field that electric current is 4mA, is passed through CO by mixed liquor2Gas, CO2The flow velocity that is passed through of gas is 20mL/min, being passed through the time is 15min, obtains the second mixed liquor;
S2, the second mixed liquor is placed in a centrifuge, 20min is centrifuged with the revolving speed of 5000r/min, sediment is removed, takes Supernatant, then supernatant is dissolved in the first diethyl ether solution of 30 parts by weight, third mixed liquor is obtained, then sets third mixed liquor The water-bath heating and refluxing extraction 40min at 70 DEG C, filtering, obtains the first solids, wherein ether and water in the first diethyl ether solution Volume ratio is 2:1;
S3, the ether that 30 parts by weight are added into the first solids and 50 parts by weight water and be uniformly mixed, add 20 The quick lime of parts by weight filters after stirring 20min, obtains the second solids, then the second solids is dissolved in 4 DEG C of 30 parts by weight In second diethyl ether solution, then diethyl ether solution to be heated to no ether smell evolution with the speed of 5 DEG C/min until, filtering is done It is dry, obtain tetrandrine, wherein the volume ratio of ether and water is 1:3 in the second diethyl ether solution.
Embodiment 2:
The present invention provides a kind of for treating the extracting method of the tetrandrine of rat microwave radiation cerebral injury, comprising:
S1, it takes the Fourstamen Stephania Root of 120 parts by weight to clean, dry, crush, Fourstamen Stephania Root powder is obtained, then into Fourstamen Stephania Root powder The water of 500 parts by weight and the solid sodium chloride of 50 parts by weight is added, then is placed in the ultrasonic wave of 50kHz and handles 30min, obtains first Then first mixed liquor is placed in the electric field that electric current is 8mA, is passed through CO by mixed liquor2Gas, CO2The flow velocity that is passed through of gas is 20mL/min, being passed through the time is 25min, obtains the second mixed liquor;
S2, the second mixed liquor is placed in a centrifuge, 30min is centrifuged with the revolving speed of 8000r/min, sediment is removed, takes Supernatant, then supernatant is dissolved in the first diethyl ether solution of 50 parts by weight, third mixed liquor is obtained, then sets third mixed liquor The water-bath heating and refluxing extraction 50min at 80 DEG C, filtering, obtains the first solids, wherein ether and water in the first diethyl ether solution Volume ratio is 2:1;
S3, the ether that 50 parts by weight are added into the first solids and 80 parts by weight water and be uniformly mixed, add 30 The quick lime of parts by weight filters after stirring 30min, obtains the second solids, then the second solids is dissolved in 4 DEG C of 50 parts by weight In second diethyl ether solution, then diethyl ether solution to be heated to no ether smell evolution with the speed of 5 DEG C/min until, filtering is done It is dry, obtain tetrandrine, wherein the volume ratio of ether and water is 1:3 in the second diethyl ether solution.
Embodiment 3:
The present invention provides a kind of for treating the extracting method of the tetrandrine of rat microwave radiation cerebral injury, comprising:
S1, it takes the Fourstamen Stephania Root of 110 parts by weight to clean, dry, crush, Fourstamen Stephania Root powder is obtained, then into Fourstamen Stephania Root powder The water of 400 parts by weight and the solid sodium chloride of 40 parts by weight is added, then is placed in the ultrasonic wave of 40kHz and handles 25min, obtains first Then first mixed liquor is placed in the electric field that electric current is 6mA, is passed through CO by mixed liquor2Gas, CO2The flow velocity that is passed through of gas is 20mL/min, being passed through the time is 20min, obtains the second mixed liquor;
S2, the second mixed liquor is placed in a centrifuge, 25min is centrifuged with the revolving speed of 6500r/min, sediment is removed, takes Supernatant, then supernatant is dissolved in the first diethyl ether solution of 40 parts by weight, third mixed liquor is obtained, then sets third mixed liquor The water-bath heating and refluxing extraction 45min at 75 DEG C, filtering, obtains the first solids, wherein ether and water in the first diethyl ether solution Volume ratio is 2:1;
S3, the ether that 40 parts by weight are added into the first solids and 65 parts by weight water and be uniformly mixed, add 25 The quick lime of parts by weight filters after stirring 25min, obtains the second solids, then the second solids is dissolved in 4 DEG C of 45 parts by weight In second diethyl ether solution, then diethyl ether solution to be heated to no ether smell evolution with the speed of 5 DEG C/min until, filtering is done It is dry, obtain tetrandrine, wherein the volume ratio of ether and water is 1:3 in the second diethyl ether solution.
Embodiment 4:
On the basis of embodiment 3, the partial size of Fourstamen Stephania Root powder is 90nm in step S1.
Embodiment 5:
On the basis of embodiment 3, in step S3 when quick lime is added, N is passed through with the flow velocity of 10mL/min2Gas, N2 The time that is passed through of gas is 30min.
Embodiment 6:
On the basis of embodiment 3, the first solids needs to be purified before ether and water is added in step S3, purifies Process are as follows: the first solids is dissolved in the ether of 12 parts by weight, then hands over the cation of the ether dissolved with the first solids Change resins exchange absorption, then with diethylether-ethanol solution elute adsorption saturation cation exchange resin column, flow velocity 5mL/min, Until outflow eluent inanimate object alkali reaction, the volume ratio of ether and ethyl alcohol is 1:2 in diethylether-ethanol solution.
Embodiment 7:
On the basis of embodiment 3, dry in step S3 is that cryogenic vacuum is spray-dried, and cryogenic vacuum is spray-dried true Reciprocal of duty cycle is 7Pa, and temperature is 60 DEG C.
Comparative example 1:
Compared with Example 3, the mass fraction that 200 parts by weight are directly added in step S1 into the first mixed liquor is 20% Carbon acid solution, obtain the second mixed liquor, other are same as Example 3.
Comparative example 2:
Compared with Example 3, the second solids is dissolved in 4 DEG C of the water of 45 parts by weight again in step S3, filtering is done It is dry, tetrandrine is obtained, other are same as Example 3.
Interpretation of result
1, it using the yield and purity of HPLC chromatogram measurement embodiment 3~7 and the resulting tetrandrine of comparative example 1~2, produces Rate=(weight/Fourstamen Stephania Root weight of tetrandrine) × 100%, purity=(weight/product weight of tetrandrine) × 100%, it the results are shown in Table 1.
The yield and purity of 1 tetrandrine of table
As known from Table 1, the yield and purity of embodiment 3~7 and the resulting tetrandrine of comparative example 1~2 have reached one Fixed height, wherein compared to embodiment 3~4, embodiment 7 and comparative example 1~2, the resulting tetrandrine of embodiment 5~6 is produced Rate and purity are higher, and the yield of embodiment 5 is up to 0.83%, and the purity of embodiment 6 is up to 98.4%, illustrate in step N is passed through when quick lime is added in S32Gas, it is possible to prevente effectively from the other compositions in Fourstamen Stephania Root are oxidized generation other impurities And be blended in product and be difficult to separate, so that the yield of tetrandrine is improved, and cation exchange resin exchange can have Effect improves the yield of tetrandrine in product, improves the purity of product;It is directly added into carbon acid solution in comparative example 1, does not there is stirring Effect, to reduce the extraction effect of tetrandrine;The yield more a height of 0.80% of the resulting tetrandrine of comparative example 2, but Purity is 83.7%, this is because the second solids to be dissolved in 4 DEG C of 45 parts by weight again in step S3 compared to embodiment 5~6 Water in, it is filtering, dry, obtain tetrandrine, rather than in the second diethyl ether solution of 45 parts by weight, be a mistake directly filtered The process of journey rather than recrystallization, also mixed with impurity not soluble in water in the product of acquisition.
2, therapeutic effect of the tetrandrine to microwave radiation brain injury in rats
2.1, experimental material:
Tetrandrine thermo-sensitive gel (weigh 12g poloxamer188,2g PLURONICS F87,1g HP- β-CD in beaker, Appropriate amount of deionized water is added, magnetic agitation makes it be uniformly dispersed, and places in 4 DEG C for 24 hours, is sufficiently swollen, it is former to form transparent blank Position gel solution.It weighs the resulting tetrandrine of appropriate embodiment 6 to be dissolved in a certain amount of 0.1mol/L hydrochloric acid, keeps it sufficiently molten Then solution adjusts pH=5 or so with 0.1mol/L sodium hydroxide, the above-mentioned blank being swollen is added in tetrandrine suspension In situ-gel solution, magnetic agitation makes it be uniformly dispersed, and 4 DEG C are placed for 24 hours, and supplement deionized water to 50mL is final to be made 50mL tetrandrine thermo-sensitive gel);
Formalin;
Wistar rat, male, weight 180-200g, SPF grade.
2.2, experimental method:
After rat adaptive feeding 5d, 6 groups are randomly divided into, i.e., normal group, model group, Blank gel group, tetrandrine temperature Quick gel 10mgkg-1、20mg·kg-1、30mg·kg-1Group, every group 10.
(water maze laboratory is the Classic Experiments for evaluating animal learning memory capability for water maze laboratory training.Water maze analysis System is made of full-automatic track acquisition system and stainless steel round pool, the high 40cm in pond, diameter 180cm, depth of water 30cm, water Temperature is kept for 22 DEG C or so, is divided into tetra- quadrants of I, II, III, IV.There is a moveable platform in pond, platform diameter is 8cm is lower than liquid level 2cm, keeps position of platform to fix in experiment.Video camera is hung right above pond, records activities in rats track, Peripheral pool is blocked with the door curtain made of cloth, and interior is kept quite.), after 3d, model is begun setting up, using the self-built high power of Academy of Military Sciences Microwave radiation simulation source, centre frequency 2.856GHz, average power density 30mW/cm2;Pulsewidth fixes 500ns;Repetition rate 1000Hz;Peak power density is respectively 200W/cm2, irradiation time 15min.Specific method of radiating are as follows: fix each group rat In organic glass radiation seed, radiation seed is placed in rotatable radiation table in microwave dark room, microwave source uniform spoke from top to bottom It penetrates, the irradiation of normal rats row equal conditions puppet.The same day after microwave radiation, administration group rat are respectively adopted self-control delivery device and carry out Nasal-cavity administration, continuous 8d, is administered twice a day, and being administered daily volume is 0.5mLkg-1;Normal group and model group are not processed. Experiment, which is divided into, finds platform training, orientation navigation experiment and space exploration experiment three parts.
1. finding platform training: rat being close on the inside of I quadrant cell wall, gently into the water towards cell wall, is started simultaneously at Record track of swimming in rat 60s.If platform is found and rested on to rat in 60s, trajectory track stops at once, if rat 60s Inside fail to find platform, it is guided to appear on the stage, and it is kept to stop 20s in platform with consolidating memory, is then sequentially completed II~IV Quadrant, taking-up put back to mouse cage after drying.Training 1 time daily, continuous 3d.
2. orientation navigation experiment: the 3rd, 4,5d orientation navigation experiment is carried out after administration, by rat successively from four quadrants Into the water, the time that platform is found in 60s, as average escape latency AEL (the Average Escape of the quadrant are recorded Latency), if failing to find platform in rat 60s, AEL will be recorded as 60s, and rat is not required to stop in platform, into it is next as Limit test.The average value of four quadrant AEL is the AEL that this tests the animal.During test, water is replaced daily, keeps water The clean free from extraneous odour in pond.
3. space exploration is tested: 7d progress space exploration is tested to detect the spatial memory capacity of rat after administration, Platform is removed, using the opposite side quadrant for being placed with platform quadrant as water-drop point, into the water by rat, observes rat in 60s Across the number of platform position.
4. spacious field is tested: for evaluating autonomic activities and exploratory behavior of the rat in free environments, experimental provision is by spacious field Reaction chamber and automatic data collection, processing system composition.Square of the spacious field reaction chamber bottom surface for long 100cm, the high 40cm of surrounding, Bottom edge and surrounding are grey black, are equipped with digital camera head at 150cm right above reaction chamber to monitor tracking rat behavior.Experiment In, bottom surface square area (40cm × 40cm) is defined as middle section, rat is placed in spacious field center, while opening automatic view Frequency tracking system, total activity distance, central movable distance, average speed and activity trajectory in record rat five minutes.Experiment Room is kept quite, and human interference is excluded.After every rat experiment, 75% ethanol solution wipes bottom and tank wall, keeps clear It is clean, the interference of rat smell before exclusion.
After 8d is administered, after the anesthesia of 1% yellow Jackets is injected intraperitoneally according to 30mg/kg in each group rat, sacrificed by decapitation, i.e., It carves and takes out rat whole brain, every group 3.After 10% formalin solution fixes 2 weeks, along hippocampus maximum coronal-plane, thickness about 3mm is cut Thin slice is placed in embedded box, and flowing water rinses fixture and precipitating, through conventional dehydration with it is transparent, waxdip with embed after be cut into thickness For 3 μm of thin slice, conventional H E dyeing is carried out after dry, neutral gum mounting is observed with optical microscopy and acquires picture.
2.3 interpretation of result
2.3.1, influence of the tetrandrine to microwave radiation brain injury in rats cognitive function
As shown in Figures 1 to 3, orientation navigation experiment is the results show that the 4th, 5d, model group rats average escape after microwave radiation More normal group of incubation period dramatically increases (P < 0.05), shows 30mW/cm2Microwave radiation can lead under learning and memory in rats ability Drop, tetrandrine 10,20mgkg-1Administration group, average escape latency significantly reduce (P < 0.05) compared with model group, Blank gel Group, tetrandrine 30mgkg-1Administration group no difference of science of statistics.The space exploration experimental result of 7d is shown after microwave radiation, The number of model group rats across position of platform more normally organizes significant decrease (P < 0.01), tetrandrine 10,20mgkg-1Administration The number of group, rat across position of platform dramatically increases (P < 0.05) compared with model group, Blank gel group, tetrandrine 30mg kg-1Administration group no significant difference (P > 0.05) compared with model group.Tetrandrine 10,20mgkg-1Administration group can significantly change The cognitive function of kind microwave radiation brain injury in rats, improves Spatial memory ability.
2.3.2, tetrandrine probes into microwave radiation brain injury in rats and the influence of independent behaviour
In spacious field experiment, the motion profile record of rat such as Fig. 4~7, through statistical analysis, model group rats total activity road Journey, average speed and middle section distance account for the ratio of total distance, and substantially less than normal group (P < 0.01), tetrandrine 10, 20mg·kg-1Administration group rat total activity distance (P < 0.01), average speed (P < 0.01) and middle section distance account for total distance Ratio (P < 0.05) dramatically increased compared with model group.Blank gel group, tetrandrine 30mgkg-1Administration group and model group Compared to no significant difference (P > 0.05).Tetrandrine 10,20mgkg-1It is big that administration group can dramatically increase microwave radiation cerebral injury The independent behaviour and spirit of exploration of mouse.
2.3.3, the influence that tetrandrine damages Rat hippocampus morphosis
As shown in figure 8, the hippocampal tissue of normal rats is in normal morphology, neuron sharpness of border, nucleus caryogram rule Whole, the light dye of cytoplasm, model group rats nucleus is triangular in shape or shuttle shape, karyopycnosis contaminate deeply, to scheme sea in C and figure A in such as Fig. 8 Ma Qu is more obvious, tetrandrine 10,20mgkg-1Administration group can significantly improve this phenomenon.
2.3.4, influence of the tetrandrine to Rat hippocampus ultrastructure damage
Neuron is as shown in Figure 9: normal rats, and hippocampal neuron chromatin is uniform, and caryogram is regular, and endochylema is abundant, carefully Born of the same parents' device is clear in structure;Side collection is concentrated in model group rats nuclei dyeing chromaticness, and caryogram is not whole, nuclear membrane obscure boundary, mitochondrial swelling, Reticulum dilatation;Tetrandrine is low, middle dosage can significantly improve this phenomenon, and tetrandrine high dose slightly improves.
Cynapse is as shown in Figure 10: normal rats hippocampal synapse double membrane structure is clear, it is seen that presynaptic vesica and cynapse Fine and close object afterwards, model group synaptic cleft is broadening, and postsynaptic density increases, and cynapse double membrane structure is smudgy, tetrandrine Low, middle dosage is obviously improved, and high dose improves unobvious.
Blood vessel is as shown in figure 11: normal rats perivascular canal is normal, and after microwave radiation, perivascular canal is significantly broadening, powder Menispermine is low, middle dosage is obviously improved, and high dose improves unobvious.
In conclusion the continuous nasal-cavity administration of tetrandrine nasal thermosensitive gel 8 days, it is investigated by behaviouristics and pathology is seen It examines, show that tetrandrine nasal thermosensitive gel dosage is 10~20mgkg-1Rat average escape latency can be significantly reduced, Spatial memory ability is improved, rat spirit of exploration is enhanced and increases autonomic activities behavior.Pass through pathologyofbraintissue, optics Microscope observes institutional framework, and transmission electron microscope observing ultra micro institutional framework can find microwave radiation to rat cerebral tissue and mind It causes obviously to damage through member, and tetrandrine has therapeutic effect to microwave radiation cerebral injury.
Although the embodiments of the present invention have been disclosed as above, but its is not only in the description and the implementation listed With it can be fully applied to various fields suitable for the present invention, for those skilled in the art, can be easily Realize other modification, therefore without departing from the general concept defined in the claims and the equivalent scope, the present invention is simultaneously unlimited In specific details and legend shown and described herein.

Claims (6)

1. the application of tetrandrine, which is characterized in that application of the tetrandrine in treatment rat microwave radiation cerebral injury.
2. the extracting method for the tetrandrine for treating rat microwave radiation cerebral injury characterized by comprising
S1, it takes the Fourstamen Stephania Root of 100~120 parts by weight to clean, dry, crush, Fourstamen Stephania Root powder is obtained, then into Fourstamen Stephania Root powder The water of 300~500 parts by weight and the solid sodium chloride of 30~50 parts by weight is added, then is placed in the ultrasonic wave of 30~50kHz 20~30min is managed, the first mixed liquor is obtained, then the first mixed liquor is placed in the electric field that electric current is 4~8mA, is passed through CO2Gas Body, CO2The flow velocity that is passed through of gas is 20mL/min, and being passed through the time is 15~25min, obtains the second mixed liquor;
S2, the second mixed liquor is placed in a centrifuge, 20~30min, removal precipitating is centrifuged with the revolving speed of 5000~8000r/min Object takes supernatant, then supernatant is dissolved in the first diethyl ether solution of 30~50 parts by weight, obtains third mixed liquor, then by Three mixed liquors are placed in 40~50min of water-bath heating and refluxing extraction at 70~80 DEG C, and filtering obtains the first solids, wherein the first second The volume ratio of ether and water is 2:1 in ethereal solution;
S3, the ether of 30~50 parts by weight and the water of 50~80 parts by weight are added into the first solids and is uniformly mixed, then plus Enter the quick lime of 20~30 parts by weight, is filtered after stirring 20~30min, obtain the second solids, then the second solids is dissolved in 4 DEG C 30~50 parts by weight the second diethyl ether solution in, diethyl ether solution is then heated to by no ether smell with the speed of 5 DEG C/min Until evolution, filtering, drying obtain tetrandrine, wherein the volume ratio of ether and water is 1:3 in the second diethyl ether solution.
3. as claimed in claim 2 for treating the extracting method of the tetrandrine of rat microwave radiation cerebral injury, feature It is, the partial size of Fourstamen Stephania Root powder is 80~100nm in step S1.
4. as claimed in claim 2 for treating the extracting method of the tetrandrine of rat microwave radiation cerebral injury, feature It is, in step S3 when quick lime is added, N is passed through with the flow velocity of 10mL/min2Gas, N2Gas be passed through the time be 25~ 35min。
5. as claimed in claim 2 for treating the extracting method of the tetrandrine of rat microwave radiation cerebral injury, feature It is, the first solids needs to be purified before ether and water is added in step S3, purification process are as follows: the first solids is molten In the ether of 10~15 parts by weight, it then will be dissolved with the ether cation exchange resin exchange adsorption of the first solids, then The cation exchange resin column of adsorption saturation, flow velocity 5mL/min are eluted with diethylether-ethanol solution, until outflow eluent is without life Until alkaloids are reacted, the volume ratio of ether and ethyl alcohol is 1:2 in diethylether-ethanol solution.
6. as claimed in claim 2 for treating the extracting method of the tetrandrine of rat microwave radiation cerebral injury, feature It is, dry in step S3 is that cryogenic vacuum is spray-dried, and the vacuum degree of cryogenic vacuum spray drying is 6~8Pa, temperature 60 ℃。
CN201910536829.6A 2019-06-20 2019-06-20 Application of tetrandrine and extraction method of tetrandrine Active CN110179799B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910536829.6A CN110179799B (en) 2019-06-20 2019-06-20 Application of tetrandrine and extraction method of tetrandrine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910536829.6A CN110179799B (en) 2019-06-20 2019-06-20 Application of tetrandrine and extraction method of tetrandrine

Publications (2)

Publication Number Publication Date
CN110179799A true CN110179799A (en) 2019-08-30
CN110179799B CN110179799B (en) 2021-02-26

Family

ID=67722611

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910536829.6A Active CN110179799B (en) 2019-06-20 2019-06-20 Application of tetrandrine and extraction method of tetrandrine

Country Status (1)

Country Link
CN (1) CN110179799B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110433132A (en) * 2019-08-19 2019-11-12 中国人民解放军军事科学院军事医学研究院 The tetrandrine nasal formulations for treating posttraumatic stress disorder

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101288695A (en) * 2007-04-16 2008-10-22 中国科学院成都生物研究所 Preparation technique of alkaloids from Stephania tetrandra
CN101955486A (en) * 2010-05-26 2011-01-26 南京泽朗医药科技有限公司 Method for extracting tetrandrine
CN102382119A (en) * 2011-10-19 2012-03-21 陕西省西安植物园 Extraction method of tetrandrine and demethyltetrandrine
CN104193754A (en) * 2014-09-04 2014-12-10 南京标科生物科技有限公司 New method for extracting tetrandrine from radix stephaniae tetrandrae
CN107496508A (en) * 2017-08-18 2017-12-22 合肥丰洁生物科技有限公司 A kind of preparation method of Fourstamen Stephania Root alkaloid
CN108218885A (en) * 2018-01-25 2018-06-29 安徽诚亚生物科技有限公司 A kind of extracting method of the tetrandrine of improvement

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101288695A (en) * 2007-04-16 2008-10-22 中国科学院成都生物研究所 Preparation technique of alkaloids from Stephania tetrandra
CN101955486A (en) * 2010-05-26 2011-01-26 南京泽朗医药科技有限公司 Method for extracting tetrandrine
CN102382119A (en) * 2011-10-19 2012-03-21 陕西省西安植物园 Extraction method of tetrandrine and demethyltetrandrine
CN104193754A (en) * 2014-09-04 2014-12-10 南京标科生物科技有限公司 New method for extracting tetrandrine from radix stephaniae tetrandrae
CN107496508A (en) * 2017-08-18 2017-12-22 合肥丰洁生物科技有限公司 A kind of preparation method of Fourstamen Stephania Root alkaloid
CN108218885A (en) * 2018-01-25 2018-06-29 安徽诚亚生物科技有限公司 A kind of extracting method of the tetrandrine of improvement

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张雄等: "粉防己碱对鼠脑缺血海马神经细胞的保护作用", 《同济医科大学学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110433132A (en) * 2019-08-19 2019-11-12 中国人民解放军军事科学院军事医学研究院 The tetrandrine nasal formulations for treating posttraumatic stress disorder
CN110433132B (en) * 2019-08-19 2023-06-30 中国人民解放军军事科学院军事医学研究院 Tetrandrine nasal preparation for treating post-traumatic stress disorder

Also Published As

Publication number Publication date
CN110179799B (en) 2021-02-26

Similar Documents

Publication Publication Date Title
CN110179799A (en) The application of tetrandrine and the extracting method of tetrandrine
CN106937959A (en) A kind of antitumor extra large Blatta seu periplaneta extract and its preparation technology and detection method and purposes
CA3053925A1 (en) Titanium-molybdate and method for making the same
CN110201118A (en) A kind of Chinese medicine composition treats or prevents the application in vascular senile dementia drug in preparation
CN102786414A (en) Compound for treating and/or preventing neurodegenerative related disease
Tang et al. Extraction of polysaccharides from Spirulina with boiling water
CN101829195B (en) Preparation method of corydalis ochotensis total alkaloid
CN107056868A (en) Epigynum Auritum pregnane glucoside compound and its application
Gul et al. Biofabrication of silver nanoparticles using Spirulina platensis: In vitro anti‐coagulant, thrombolytic and catalytic dye degradation activity
CN105503895A (en) Novel diterpene compound for treating acute T lymphocytic leukemia
CN111349046B (en) Alkaloid, crystal, preparation method and application
CN103948596A (en) Application for oleracein E in preparation for medicine for resisting dementia neurodegenerative diseases
Maghami et al. Green Fabrication of Albizia Lebbeck Leaves-Capped Silver Nanoparticles for Removal of Butylparaben
Arundoss et al. ARTICLE INFO ABSTRACT
CN102631314B (en) Method for preparing sinomenine hydrochloride eye drops
Brobst et al. The free base extraction of harmaline from Peganum harmala
Kombo et al. Traditional medicines and experimental analysis methods for Alzheimer’s disease
JP2007308614A (en) Cell death inhibitor or the like of nerve cell
Serdar Green Biosynthesis of Silver Nanoparticles were Obtained from the Extract of Pomegranate (Punica granatum L.) Leaves by Supercritical Extraction Using Microwave Method
CN107050041A (en) Polysaccharide from Portulaca oleracea prevents and treats the application caused by lead exposure in the medicine or food of Spatial memory impairment in preparation
Guihua et al. Microwave Technique for Polysaccharide Extraction from Dendrobium huoshanense.
CN109091484A (en) A kind of pharmaceutical composition preventing and treating alzheimer&#39;s disease
CN109223786A (en) Application of the Dauricine in the drug of preparation treatment Alzheimer&#39;s disease mitochondria
Ou et al. Extraction and anti-inflammatory effects of colchicine from Sagittaria sagittifolia
CN108078983B (en) A kind of application of bis-indole compounds in terms of preparing anti-inflammatory drug

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant